{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"description":"The eye was visualized using a slit-lamp microscope in a procedure room.","groups":[{"description":"A superficial corneal epithelial tissue specimen was obtained by performing impression cytology (IC) procedure in participants with relapsed/refractory multiple myeloma (RRMM) treated with belantamab mafodotin. The procedure was only performed in one eye. Participants did not need to be on active treatment.","id":"OG000","title":"Participants Allocated to Undergo Impression Cytology Procedure"},{"description":"A superficial corneal epithelial tissue specimen was obtained by performing superficial keratectomy (SK) procedure in participants with relapsed/refractory multiple myeloma (RRMM) treated with belantamab mafodotin. The procedure was only performed in one eye. Participants did not need to be on active treatment.","id":"OG001","title":"Participants Allocated to Undergo Superficial Keratectomy Procedure"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"ICSK Population","reportingStatus":"POSTED","timeFrame":"Up to approximately 23 months","title":"Number of Participants With Imaging Data Showing Histopathologic Findings","type":"SECONDARY","unitOfMeasure":"Participants"}